Thursday, 18 April 2024
Allena Pharmaceuticals Inc.
22:56 | 14/3/18
Frisco Fastball
More notable recent Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) news were published by: Streetinsider.com which released: “Allena Pharmaceuticals (ALNA) Initiates First Phase 3 Trial for ALLN-177 in …” on March 06, 2018, also Marketwatch.
more»
01:56 | 8/3/18
GlobeNewswire
NEWTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with ...
more»
02:07 | 7/3/18
StreetInsider.com
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today ...
more»
01:56 | 7/3/18
GlobeNewswire
NEWTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and ...
more»
07:45 | 5/3/18
Frisco Fastball
More notable recent Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) news were published by: Globenewswire.com which released: “Allena Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering” on November 02, 2017, also Gurufocus.com with their ...
more»
22:56 | 3/3/18
Frisco Fastball
Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States.
more»
07:33 | 3/3/18
Frisco Fastball
More notable recent Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) news were published by: Marketwatch.com which released: “Allena Pharmaceuticals seeks $92 million in initial public offering” on October 06, 2017, also Marketwatch.
more»
13:45 | 27/2/18
StockNewsTimes
Wall Street brokerages expect Allena Pharmaceuticals Inc (NASDAQ:ALNA) to report ($0.27) earnings per share for the current quarter, Zacks reports.
more»
06:03 | 26/2/18
The Ledger Gazette
ValuEngine raised shares of Allena Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Friday, February 2nd.
more»
02:41 | 25/2/18
StockNewsTimes
Allena Pharmaceuticals Inc (NASDAQ:ALNA) - Analysts at Jefferies Group decreased their FY2017 earnings per share estimates for Allena Pharmaceuticals in a research report issued on Tuesday, according to Zacks Investment Research.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |